TherapeuticsMD, Inc. TXMD

Full chart Compare
Set alert

Price alert · TXMD

All alert types
1.82 USD +0.04 (+2.25%)

At closeNov 4, 2026, 4:00 PM EST

1.82 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

1.75 Day range 1.82
1.11 52-week range 2.95
YTD
+11.66%
1 year
+55.56%

Revenue & Expenses

Revenue by
Other Income → Expenses: $3.65MExpenses → Selling, General & Admin: $6.85MExpenses → Other Operating Expenses: $384.00KUnited States → Revenue: $1.79MGross Profit → Expenses: $3.02MRevenue → Gross Profit: $3.02MNon-US → Revenue: $1.23MNet Loss → Expenses: $569.00KOther Income$3.65MGross Profit$3.02MNet Loss$569.00KExpenses$7.24MSelling, General & Admin$6.85MOther Operating Expenses$384.00KRevenue$3.02MUnited States$1.79MNon-US$1.23M

Latest period ending Dec 31, 2025 · select a line to chart its full history

TXMD annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
3.02M1.76M1.30M69.96M2.57M
3.02M1.76M1.30M68.57M1.17M
-4.39M-6.11M-8.52M1.19M-79.58M
-569.00K-2.18M-10.28M112.00M-172.41M
-0.05-0.19-0.9911.96-21.66
TXMD annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
7.48M5.06M4.33M49.32M64.91M
37.66M38.82M43.31M90.46M169.47M
10.78M11.45M14.02M55.31M263.09M
5.12M5.54M6.53M7.37M196.33M
26.88M27.37M29.29M35.14M-93.62M
TXMD annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-30.00K-438.00K-48.14M-4.08M-142.69M
2.42M732.00K-44.99M-15.80M-15.36M